Profile - To The Moon

HelloFluffy

Posts · 9Posts · 9
Following · 0Following · 0
Followers · 0Followers · 0

- HelloFluffyHelloFluffy
  ·2021-06-19
  Another Jack Ma?
  Sorry, this post has been deleted
  72 Comment
  2
  Share
  Report
- HelloFluffyHelloFluffy
  ·2021-06-17
  $Qualys(QLYS)$ Slow & steady
  109 Comment
  1
  Share
  Report
- HelloFluffyHelloFluffy
  ·2021-05-07
  Medifast means moving fast ?
  3 Reasons Why Medifast (MED) Is a Great Growth Stock
  Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, the task of finding cutting-edge growth stocks is
  3 Reasons Why Medifast (MED) Is a Great Growth Stock
  274 2
  2
  Share
  Report
- HelloFluffyHelloFluffy
  ·2021-05-06
  Hope qualys continue to beat estimation
  Sorry, this post has been deleted
  138 1
  2
  Share
  Report
- HelloFluffyHelloFluffy
  ·2021-05-05
  Are you serious?
  35 Comment
  Like
  Share
  Report
- HelloFluffyHelloFluffy
  ·2021-05-05
  Is this stock a hidden gem?
  113 Comment
  Like
  Share
  Report
- HelloFluffyHelloFluffy
  ·2021-01-01
  Hi......
  155 1
  Like
  Share
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":3572342871727454,"uuid":"3572342871727454","gmtCreate":1609251405555,"gmtModify":1619257759845,"name":"HelloFluffy","pinyin":"hellofluffy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/602c31b63101c53fa95403254f96815c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":5,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":4,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":162265426,"gmtCreate":1624065144465,"gmtModify":1703827931730,"author":{"id":"3572342871727454","authorId":"3572342871727454","name":"HelloFluffy","avatar":"https://static.tigerbbs.com/602c31b63101c53fa95403254f96815c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Another Jack Ma?&nbsp;","listText":"Another Jack Ma?&nbsp;","text":"Another Jack Ma?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/162265426","repostId":"2144642724","repostType":2,"isVote":1,"tweetType":1,"viewCount":72,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161381638,"gmtCreate":1623905166324,"gmtModify":1703823168425,"author":{"id":"3572342871727454","authorId":"3572342871727454","name":"HelloFluffy","avatar":"https://static.tigerbbs.com/602c31b63101c53fa95403254f96815c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QLYS\">$Qualys(QLYS)$</a>&nbsp;Slow &amp; steady","listText":"<a href=\"https://laohu8.com/S/QLYS\">$Qualys(QLYS)$</a>&nbsp;Slow &amp; steady","text":"$Qualys(QLYS)$ Slow & steady","images":[{"img":"https://static.tigerbbs.com/edba2327c67c5d7788419d32bfc94aed","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161381638","isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":104629123,"gmtCreate":1620386672362,"gmtModify":1704342914846,"author":{"id":"3572342871727454","authorId":"3572342871727454","name":"HelloFluffy","avatar":"https://static.tigerbbs.com/602c31b63101c53fa95403254f96815c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Medifast means moving fast ?","listText":"Medifast means moving fast ?","text":"Medifast means moving fast ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/104629123","repostId":"2133526997","repostType":2,"repost":{"id":"2133526997","pubTimestamp":1620233104,"share":"https://www.laohu8.com/m/news/2133526997?lang=&edition=full","pubTime":"2021-05-06 00:45","market":"us","language":"en","title":"3 Reasons Why Medifast (MED) Is a Great Growth Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2133526997","media":"Zacks","summary":"Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, the task of finding cutting-edge growth stocks is","content":"<html><body><p>Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.</p>\n<p>By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.</p>\n<p>However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.</p>\n<p>Medifast (MED) is <a href=\"https://laohu8.com/S/AONE\">one</a> such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.</p>\n<p>Research shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.</p>\n<p>Here are three of the most important factors that make the stock of this weight-loss company a great growth pick right now.</p>\n<p><b>Earnings Growth</b></p>\n<p>Arguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.</p>\n<p>While the historical EPS growth rate for Medifast is 46.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 19.1% this year, crushing the industry average, which calls for EPS growth of 10%.</p>\n<p><b>Cash Flow Growth</b></p>\n<p>While cash is the lifeblood of any business, higher-than-average cash flow growth is more important and beneficial for growth-oriented companies than for mature companies. That's because, growth in cash flow enables these companies to expand their businesses without depending on expensive outside funds.</p>\n<p>Right now, year-over-year cash flow growth for Medifast is 45%, which is higher than many of its peers. In fact, the rate compares to the industry average of 2.6%.</p>\n<p>While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 32.7% over the past 3-5 years versus the industry average of 5.8%.</p>\n<p><b>Promising Earnings Estimate Revisions</b></p>\n<p>Beyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.</p>\n<p>There have been upward revisions in current-year earnings estimates for Medifast. The Zacks Consensus Estimate for the current year has surged 0.4% over the past month.</p>\n<p><b>Bottom Line</b></p>\n<p>Medifast has not only earned a Growth Score of A based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.</p>\n<p>You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.</p>\n<p>This combination positions Medifast well for outperformance, so growth investors may want to bet on it.</p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\nMEDIFAST INC (MED) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.\n<br/> \n<br/>\nZacks Investment Research</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Reasons Why Medifast (MED) Is a Great Growth Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Reasons Why Medifast (MED) Is a Great Growth Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-06 00:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/3-reasons-why-medifast-med-164504998.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that...</p>\n\n<a href=\"https://finance.yahoo.com/news/3-reasons-why-medifast-med-164504998.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/YsLi38.JNFUFos53LSrRtQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Tw87WEC1wh0JNb8.IBuFMA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/03fca48475577988aa4e0db94f484b4e","relate_stocks":{"MED":"快验保"},"source_url":"https://finance.yahoo.com/news/3-reasons-why-medifast-med-164504998.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2133526997","content_text":"Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.\nBy their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.\nHowever, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.\nMedifast (MED) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.\nResearch shows that stocks carrying the best growth features consistently beat the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.\nHere are three of the most important factors that make the stock of this weight-loss company a great growth pick right now.\nEarnings Growth\nArguably nothing is more important than earnings growth, as surging profit levels is what most investors are after. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.\nWhile the historical EPS growth rate for Medifast is 46.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 19.1% this year, crushing the industry average, which calls for EPS growth of 10%.\nCash Flow Growth\nWhile cash is the lifeblood of any business, higher-than-average cash flow growth is more important and beneficial for growth-oriented companies than for mature companies. That's because, growth in cash flow enables these companies to expand their businesses without depending on expensive outside funds.\nRight now, year-over-year cash flow growth for Medifast is 45%, which is higher than many of its peers. In fact, the rate compares to the industry average of 2.6%.\nWhile investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 32.7% over the past 3-5 years versus the industry average of 5.8%.\nPromising Earnings Estimate Revisions\nBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.\nThere have been upward revisions in current-year earnings estimates for Medifast. The Zacks Consensus Estimate for the current year has surged 0.4% over the past month.\nBottom Line\nMedifast has not only earned a Growth Score of A based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.\nYou can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.\nThis combination positions Medifast well for outperformance, so growth investors may want to bet on it.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nMEDIFAST INC (MED) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.\n \n\nZacks Investment Research","news_type":1},"isVote":1,"tweetType":1,"viewCount":274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":105109011,"gmtCreate":1620274783133,"gmtModify":1704341190879,"author":{"id":"3572342871727454","authorId":"3572342871727454","name":"HelloFluffy","avatar":"https://static.tigerbbs.com/602c31b63101c53fa95403254f96815c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hope qualys continue to beat estimation","listText":"Hope qualys continue to beat estimation","text":"Hope qualys continue to beat estimation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/105109011","repostId":"2133529106","repostType":2,"isVote":1,"tweetType":1,"viewCount":138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102524745,"gmtCreate":1620225363387,"gmtModify":1704340477134,"author":{"id":"3572342871727454","authorId":"3572342871727454","name":"HelloFluffy","avatar":"https://static.tigerbbs.com/602c31b63101c53fa95403254f96815c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Are you serious?&nbsp;","listText":"Are you serious?&nbsp;","text":"Are you serious?","images":[{"img":"https://static.tigerbbs.com/6383884967f489bd24ed960fee05fb47","width":"1080","height":"2157"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102524745","isVote":1,"tweetType":1,"viewCount":35,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":102802141,"gmtCreate":1620190099983,"gmtModify":1704339977917,"author":{"id":"3572342871727454","authorId":"3572342871727454","name":"HelloFluffy","avatar":"https://static.tigerbbs.com/602c31b63101c53fa95403254f96815c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Is this stock a hidden gem?&nbsp;","listText":"Is this stock a hidden gem?&nbsp;","text":"Is this stock a hidden gem?","images":[{"img":"https://static.tigerbbs.com/c82c9c0c460ee613066fdbb772134d05","width":"1080","height":"2256"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102802141","isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":331880872,"gmtCreate":1609503362396,"gmtModify":1704979266393,"author":{"id":"3572342871727454","authorId":"3572342871727454","name":"HelloFluffy","avatar":"https://static.tigerbbs.com/602c31b63101c53fa95403254f96815c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Hi......&nbsp;","listText":"Hi......&nbsp;","text":"Hi......","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/331880872","isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0},"content":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation","text":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation","html":"Finally, when you first post [compare heart] [compare heart] post, you can get more exposure by related stocks or related topics. If you want to create high-quality articles, please checkGuidelines for Tiger Community Creation"}],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}